我在那里看病人 (3)
我的评论
选择研究
-
oric - 101, 糖皮质激素受体拮抗剂, nab -紫杉醇联合治疗晚期实体瘤.
癌症研究通讯
-
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170).
癌症研究通讯
-
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.
精准肿瘤学
临床试验
胰腺癌筛查的初步研究
Proportion of participants with an abnormal MRI finding will 报告 as an event. An estimated event rate of 19% in participants with a strong family history (FH) of 胰腺癌和10%没有st的十大赌博靠谱网络平台者...
招聘
4.8